Elizabeth Wright
As seen in:
Medium,
The Guardian,
ABC News (Australia),
Tes,
JSTOR Daily,
MDPI,
HuffPost UK,
The Hill,
Fox Business,
The Daily Caller
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Elizabeth Wright
Worth It or a Waste of Money?
Planning a trip to Universal Orlando is exciting! However, a lot of work goes into planning the perfect theme park vacation, as you want to ensure you get the most out of your time and budget. You can either purchase single-day tickets or splurge on a park-to-park ticket, which allows you to bounce between multiple theme parks throughout the day. With the higher price tag, many travelers wonder if a Universal park-to-park ticket is worth it.
Regulatory Pulse Pharma And Medical Devices Newsletter: Issue #5
Welcome to Issue #5 of Regulatory Pulse: Pharma and Medical Devices Newsletter. This newsletter is a monthly source for the latest updates and insights on regulatory developments in the pharmaceutical and medical device industries. It provides comprehensive coverage of new regulations, guidelines and compliance requirements from EU regulatory bodies and other key agencies. Please share this subscription link with others who want to subscribe to this newsletter.
Regulatory Pulse Pharma And Medical Devices Newsletter: Issue #3
The European Health Data Space Regulation (EHDS Regulation) entered into force on March 26, 2025. The purpose of the Regulation is to establish a common framework for the use and exchange of electronic health data across the EU. This includes the enhancement of individuals' access to and control over their personal electronic health data, and the smooth functioning of the internal market.
Regulatory Pulse Pharma And Medical Devices Newsletter: March 2025
The European Commission has published an implementing regulation related to the Health Technology Assessment Regulation (HTA Regulation) that concerns joint scientific consultations on medical devices andin vitrodiagnostic devices.
Regulatory Pulse Pharma And Medical Devices Newsletter: February 2025
In a recent interview Commissioner Olivér Várhelyi outlined his main priorities for EU health policy. He believes that the EU's competitive must bolstered. A proposal for a Biotech Act and completion of the revision of the Pharmaceutical legislation are, consequently, important priorities for him. The proposal for a Biotech Act is part of the Communication on Building the future with nature published by the European Commission in 2024.
Comedian Adam Hills is fighting for the inclusion of para-standing tennis at the Paralympics
Due to his latest obsession, comedian Adam Hills jokes he no longer sees his children and his marriage is strained. The 54-year-old is making history representing Australia in para-standing tennis, this year charging into the quarterfinals of the World Championships with his doubles partner, ATP-ranked Alex Hunt. This came only days after making the European Championship final with Hunt.
Para sports push for greater support to ensure they feature at Brisbane 2032 ...
www.abc.net.au is blocked www.abc.net.au refused to connect.
The Parafencer hoping to break a 50-year drought
www.abc.net.au is blocked www.abc.net.au refused to connect.
Archer Ameera Lee targets a spot at Paris Paralympics
www.abc.net.au is blocked www.abc.net.au refused to connect.
EMA Adopts Revised CTIS Transparency Rules
On 5 October 2023, the European Medicines Agency (EMA) adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System (CTIS). The CTIS plays a fundamental role in facilitating the exchange of clinical trial information within the European Union (EU), as provided in the Clinical Trials Regulation (CTR).
EMA Adopts Revised CTIS Transparency Rules | JD Supra
On 5 October 2023, the European Medicines Agency (EMA) adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System (CTIS). The CTIS plays a fundamental role in facilitating the exchange of clinical trial information within the European Union (EU), as provided in the Clinical Trials Regulation (CTR).
EMA Adopts Revised CTIS Transparency Rules
On 5 October 2023, the European Medicines Agency (EMA) adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System (CTIS). The CTIS plays a fundamental role in facilitating the exchange of clinical trial information within the European Union (EU), as provided in the Clinical Trials Regulation (CTR).
EU Study Investigates Different Models For Directly Shipping Drugs To Patients
On 12 July 2023, a study was published in the British Journal of Clinical Pharmacology on different models in Europe for directly shipping drugs to patients during decentralized clinical trials (DCTs ), which are conducted in environments such as a participant's home or a local address, rather than investigative sites.
EU Study Investigates Different Models for Directly Shipping Drugs to Patients
Although the European Union lacks harmonised requirements related to the shipping of IMPs directly to study participants, trial sponsors have been experimenting with different approaches. DtP supply of IMPs and DCT models were important to on-going activities related to clinical trials conducted during the COVID-19 pandemic. Previous research already suggested that EU law would not prohibit home shipping or administration of medicinal products for use in conducting a clinical trial.
European Commission Adopts Directive Extending Time Lead Can Be Used In PVC Sensors Of IVDs
The European Commission has adopted Commission Delegated Directive (EU) 2023/1526, which amends Directive 2011/65/EU of the European Parliament and European Council as regards an exemption for lead as a thermal stabilizer in polyvinyl chloride (PVC) used as base material in sensors for in vitro diagnostic medical devices (IVDs).
European Commission Adopts Directive Extending Time Lead can be used in PVC sensors of IVDs
The European Commission has adopted Commission Delegated Directive (EU) 2023/1526, which amends Directive 2011/65/EU of the European Parliament and European Council as regards an exemption for lead as a thermal stabilizer in polyvinyl chloride (PVC) used as base material in sensors for in vitro diagnostic medical devices (IVDs).
JOJI at Rod Laver Arena, Melbourne (Lic. All Ages)
About the event JOJI at Rod Laver Arena, Melbourne (Lic. All Ages) Frontier Touring are excited to announce Australian-Japanese, US-based singer-songwriter and global sensation Joji will tour Australia and New Zealand for the first time ever, bringing his Pandemonium Tour to local audiences this November.
European Commission Publishes Guidance On Transition From Clinical Trials Directive To Clinical Trials Regulation
On 19 July 2023, the European Commission published a guidance document concerning the steps to be taken in the transition of clinical trials from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR). On 19 July 2023, the European Commission published a guidance document concerning the steps to be taken in the transition of clinical trials from the Clinical Trials Directive (CTD) to the Clinical Trials Regulation (CTR).
European Commission Publishes MDR And IVDR Factsheet For Non-EU/EEA Countries
On 12 July 2023, the European Commission published a factsheet for authorities outside the European Union (EU) and the European Economic Area (EEA) on the implications of the extended deadlines inRegulation (EU) 2017/745 on medical devices(MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). On 15 March 2023, the MDR and IVDR were amended with deadlines extended beyond the originally established date of 26 May 2024.
UK Government Provides Limited Extensions To Recognition Of CE Marks For Medical Devices In Great Britain - Healthcare - UK
On 1 August 2023, the UK government announced plans to extend recognition of CE marking 'indefinitely' for certain products placed on the Great Britain market (England, Wales and Scotland). However, medical devices are not among the categories of products concerned by the indefinite recognition of CE marking. Instead, the UK government has been working to introduce regulations to substantially reform the current regulatory framework governing medical devices in the UK.
GCP Q&A Clarifies Sponsor Role In Trial-Related Tasks, Provides Other Updates
The European Medicines Agency (EMA) has updated its Q&A for good clinical practice (GCP). The update acknowledges that the sponsor may support the investigator by identifying or contracting service providers in the conduct of the clinical trial. This update reflects the leading role of sponsors in interaction with contracting service providers when trial activities are conducted remotely during decentralized clinical trials (DCTs).
GCP Q&A Clarifies Sponsor Role in Trial-Related Tasks, Provides Other Updates
The European Medicines Agency (EMA) has updated its Q&A for good clinical practice (GCP). The update acknowledges that the sponsor may support the investigator by identifying or contracting service providers in the conduct of the clinical trial. This update reflects the leading role of sponsors in interaction with contracting service providers when trial activities are conducted remotely during decentralized clinical trials (DCTs).
The mtDNA D-Loop Legacy of Cattle: Fluctuations in Diversity from the Neolithic to Early Medieval Times in Switzerland
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by José Granado 1, Elizabeth Wright 2, Robert Blatter 1, Jürg Lange 1, Meral Turgay 1, Laura Bañuelos 1, Sabine Deschler-Erb 1,*, Barbara Stopp 1, Elisabeth Marti-Grädel 1, Marguerita Schäfer 1, Idoia Grau-Sologestoa 1, Sandra Ammann 3, Debora Schmid 3, Alex R.
European Commission Publishes Proposals to Revise Current EU Pharmaceutical Legislative Framework | JD Supra
Yesterday, the European Commission published two legislative proposals concerning the regulation of medicinal products in the European Union. The proposals seek to consolidate existing legislation into two instruments, a revised and amplified version of Directive 2001/83, the Community code on medicinal products, and a revised and amplified version of Regulation 726/2004, the European Medicines Agency (EMA) Regulation.
European Commission Publishes Proposals to Revise Current EU Pharmaceutical Legislative Framework
Yesterday, the European Commission published two legislative proposals concerning the regulation of medicinal products in the European Union. The proposals seek to consolidate existing legislation into two instruments, a revised and amplified version of Directive 2001/83, the Community code on medicinal products, and a revised and amplified version of Regulation 726/2004, the European Medicines Agency (EMA) Regulation.
Virginia Woolf’s Only Play
Ask an English major the title of Virginia Woolf’s best novel, and they’ll probably have a ready answer. Most likely, they’ll nominate the interwar social commentary Mrs. Dalloway, the experimental queer text Orlando, or even the famously dense but intellectually rewarding To the Lighthouse. Yet if asked to name Woolf’s best play, they’ll probably draw a blank.
EMA launches pilot program for expert panel scientific advice in relation to certain high-risk devices
On 27 February 2023, the EMA launched a program that will allow 10 manufacturers of certain high-risk medical devices and in vitro diagnostic medical devices (“IVDs”) to receive advice on their clinical development strategies from expert panels established in accordance with the Medical Device Regulation (EU) No. 2017/745 (“MDR”) and the In Vitro Diagnostic Medical Device Regulation (EU) No. 2017/746 (“IVDR”).
HealthComp Expands Medical Cost Management Capabilities with the Acquisition of MediOpin
There were 1,449 press releases posted in the last 24 hours and 360,545 in the last 365 days. FRESNO, CA, UNITED STATES, February 21, 2023 /EINPresswire.com/ -- In a continued effort to further HealthComp’s value proposition as a leader in medical cost management, HealthComp has acquired Atlanta-based company MediOpin, a provider of medical opinion-based reviews and medically driven cost containment services.
European Medicines Agency Publishes Q&A on Clinical Trial Data Transparency
Following the entry into application of the Clinical Trials Regulation (EU) 536/2014 (CTR) for all initial clinical trial applications on 31 January 2023, the European Medicines Agency (EMA) has published a Q&A document concerning the transparency obligations established in the CTR in relation to information submitted in support of an application.
EMA to reinstate its proactive clinical data publication policy
The EMA has announced the decision of its management board to resume its proactive clinical data publication policy after a four year-long pause. The application of the proactive publication policy will follow a staggered approach where priority will be given to data relating to new marketing authorization applications that involve new active substances.
European Commission Publishes Updated Q&A on Clinical Trials Regulation
In December 2022, the European Commission published an updated version of the Q&A guidance on the Clinical Trials Regulation (CTR). This new version was issued ahead of the 31 January 2023 deadline from which all new applications for the approval of clinical trials must be submitted in accordance with the CTR. The most important amendment to the Q&A is the inclusion of a new Annex III. The application dossier for the approval of a clinical trial in accordance with the CTR is composed of two parts.
EMA guideline on sponsor responsibility for release and shipping of IMPs in accordance with GCP and GMP in the EU comes into effect
Read an overview of the EMA guideline on clinical trial sponsor responsibility for management of IMPs The guideline on sponsor management of investigational medicinal products (“IMPs”) for use in clinical trials that was published by the European Medicines Agency (“EMA”) on 14 September 2022 (the “Guideline”) came into effect on January 1, 2023.
European Commission Proposes Amending Transitional Provisions in Medical Devices and In Vitro Diagnostics Regulations | JD Supra
On 6 January 2023, the European Commission adopted a proposal to amend the transitional provisions of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). The proposal aims to prevent medical device shortages on the European Economic Area (EEA) market.
European Commission Proposes Amending Transitional Provisions in Medical Devices and In Vitro Diagnostics Regulations
On 6 January 2023, the European Commission adopted a proposal to amend the transitional provisions of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). The proposal aims to prevent medical device shortages on the European Economic Area (EEA) market.
The EMA publishes updated Q&A on clinical trial sponsor oversight of delegated tasks
Read a summary of EMA’s updated guidance on how clinical trial sponsors can demonstrate oversight of activities delegated to third party service providers. In December 2022, the European Medicines Agency (“EMA”) published updated guidance in the form of a Q&A on how clinical trial sponsors can demonstrate oversight of the functions that they delegate to third party service providers through a written agreement.
Proposed revisions to the MDR - what will these mean in practice
The growing challenges faced by a range of stakeholders within the medical device space has led the European Commission to submit a proposal to revise the Regulation (EU) 2017/745 on medical devices (“MDR”) to extend the transitional periods foreseen by the Regulation.
Proposed revisions to the MDR - what will these mean in practice
Elizabeth Anne Wright, partner, and Anastasia Vernikou, legal trainee, at law firm Cooley explains the practicalities of any proposed revision to the EU Medical Device Regulation (MDR). The growing challenges faced by a range of stakeholders within the medical device space has led the European Commission to submit a proposal to revise the Regulation (EU) 2017/745 on medical devices (MDR) to extend the transitional periods foreseen by the Regulation.
European Commission Proposes Extending Transition Period Foreseen in Medical Devices Regulation | JD Supra
The implementation of Regulation (EU) 2017/745 on medical devices (MDR) was discussed on the second day of the meeting of the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) on 9 December 2022.
European Commission proposes extension of the transition periods foreseen in the Medical Device Regulation
The implementation of Regulation (EU) 2017/745 on medical devices (“MDR”) was discussed on the second day of the meeting of the Employment, Social Policy, Health and Consumer Affairs Council (“EPSCO”) on Friday, 9 December, 2022.
Highlander Center celebrates 90 years of strengthening Southern freedom movements | Opinion Original
We have seen the brilliance of Southern strategies for change throughout our 90 years — we have seen courageous acts of resistance and creative solutions that build new ways of life. Elizabeth Wright Guest Columnist Elizabeth Wright is the education team interim co-coordinator at the Highlander Center. "There’s a New World Coming” is a song, a promise, and a call to action.
Opinion: Carrying the torch for East London
Elizabeth Wright from English Cities Fund, which works with councils and landowners on development and regeneration, explores how East London could benefit from the city hosting a 2036 Olympic Games. Londoners will have noted with interest Sadiq Khan floating the idea the capital could once again host the Olympics. Ten years on from the success of 2012, the Mayor says he has spoken with the International Olympic Committee about London being the venue for the Games in 2036 or 2040.
Build Back Better Act Would Harm Generic Drug Industry
Build Back Better Act Would Harm Generic Drug Industry "The provisions of H.R. 3 being included in the BBBA will only make matters worse, fail to fix the underlying conditions that have distorted the marketplace, and devastate America’s robust and competitive biopharmaceutical marketplace." ~ Elizabeth Wright Read Full Article »
The Build Back Better Act Would Seriously Harm the Generic Drug Industry – InsideSources
President Joe Biden and the Democratic majority in Congress seem to believe they received a mandate in the 2020 election.
Opinion: Consumers will feel pain if pharmacy benefit managers are over-regulated
Taking on the mantle of supposedly reducing drug prices and eliminating alleged fraudulent activity within the pharmaceutical marketplace, some of Ohio’s largest newspapers and government officials are targeting pharmacy benefit managers.
Can 'WeThe15' Campaign Help Disabled People? The Disability Community Isn't So Sure
Key Takeaways Last week, global organizations headed by the IPC and UNESCO launched the biggest-ever disability rights campaign, called WeThe15. The campaign aims to improve inclusion for disabled people. Using the Tokyo Paralympics as an initial platform, WeThe15 aims to improve the lives of 1.2 billion disabled people. Many disabled people are skeptical of the campaign and how effective it could actually be.
340B Drug Discount Program Should Be on GAO’s High-Risk List | RealClearHealth
By Elizabeth Wright April 02, 2021 When a new Congress begins, the Government Accountability Office (GAO) releases its updated “High-Risk List” of programs and operations that are ‘high risk’ due to their vulnerabilities to fraud, waste, abuse, and mismanagement, or that need transformation. The 2021 version has 36 risk areas, including Department of Defense (DOD) Weapons Systems Acquisition, Medicare and Medicaid, and the National Flood Insurance Program.
Pre-Existing Conditions Will Be Covered by Whoever Wins the Election – InsideSources
During Justice Amy Coney Barrett’s nomination, Democrats spent most of their time figuratively gnashing their teeth, pulling their hair and pounding their chests about how the Patient Protection and Affordable Care Act (ACA), or Obamacare, would be ripped to shreds by the end of November if she was confirmed.
Support Debo in House District 3
Opinion | Letter She is eager to continue working hard for her community By Elizabeth Wright // Oct 5, 2020 I am writing to advocate for Debo Powers who is running for the legislative seat in House District 3. I know Debo as a friend and through my work as a fire lookout; we are both fire lookouts in House District 3. Fire lookouts are important for detecting fires early, in communications with fire personnel, and in monitoring fire activity.
Lackluster nursing home inspections added to COVID-19 deaths
While the U.S. coronavirus death toll continues to rise everywhere, the disease has been particularly deadly to residents in nursing homes. Centers for Medicare and Medicaid Services data reported 95,515 confirmed COVID-19 cases in nursing homes and 31,782 total deaths, or 33%, as of May 31. According to Kaiser Family Foundation , more than 50% of COVID-19 deaths in 27 states occurred in long-term care facilities, with the highest at 85% in Pennsylvania.
Designing greener cities? We need to give disabled people a seat at the table
Photo by Mitchell Kmetz on Unsplash “UK transport set for ‘once in a generation’ change.” I knew what the article was going to say before I’d even read it. In fact, there had been rumblings about this stuff for weeks, with many European countries already talking about it. And whilst I am not entirely against the concept, my frustration and fear about it sent my anger skyrocketing.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Elizabeth
Contact Elizabeth, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack